Larson SM - Search Results

1

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

Rathkopf DE, Larson SM, Anand A, Morris MJ, Slovin SF, Shaffer DR, Heller G, Carver B, Rosen N, Scher HI. Rathkopf DE, et al. Among authors: larson sm. Cancer. 2015 Nov 1;121(21):3853-61. doi: 10.1002/cncr.29578. Epub 2015 Jul 15. Cancer. 2015. PMID: 26178426 Free PMC article. Clinical Trial.

2

Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.

Scher HI, Curley T, Yeh S, Tong W, O'Moore PV, Larson S. Scher HI, et al. Adv Exp Med Biol. 1992;324:115-29. doi: 10.1007/978-1-4615-3398-6_12. Adv Exp Med Biol. 1992. PMID: 1283494 Review. No abstract available.

3

Therapeutic alternatives for hormone-refractory prostatic cancer.

Scher HI, Curley T, Yeh S, Iversen JM, O'Dell M, Larson SM. Scher HI, et al. Among authors: larson sm. Semin Urol. 1992 Feb;10(1):55-64. Semin Urol. 1992. PMID: 1373515 Review.

4

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.

Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM, et al. Divgi CR, et al. Among authors: larson sm. J Natl Cancer Inst. 1991 Jan 16;83(2):97-104. doi: 10.1093/jnci/83.2.97. J Natl Cancer Inst. 1991. PMID: 1988695

5

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.

Cheung NK, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM. Cheung NK, et al. Among authors: larson sm. Cancer Res. 1994 Apr 15;54(8):2228-33. Cancer Res. 1994. PMID: 8174131

6

Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.

Bergman I, Arbit E, Rosenblum M, Larson SM, Heller G, Cheung NK. Bergman I, et al. Among authors: larson sm. J Neurooncol. 1993 Mar;15(3):235-42. doi: 10.1007/BF01050069. J Neurooncol. 1993. PMID: 8360709

7

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI. Yeh SD, et al. Among authors: larson sm. Nucl Med Biol. 1996 Aug;23(6):693-7. doi: 10.1016/0969-8051(96)00044-3. Nucl Med Biol. 1996. PMID: 8940712 Clinical Trial.

8

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma.

Imbriaco M, Yeh SD, Yeung H, Zhang JJ, Healey JH, Meyers P, Huvos AG, Larson SM. Imbriaco M, et al. Among authors: larson sm. Cancer. 1997 Oct 15;80(8):1507-12. Cancer. 1997. PMID: 9338476 Clinical Trial.

9

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Slovin SF, Scher HI, Divgi CR, Reuter V, Sgouros G, Moore M, Weingard K, Pettengall R, Imbriaco M, El-Shirbiny A, Finn R, Bronstein J, Brett C, Milenic D, Dnistrian A, Shapiro L, Schlom J, Larson SM. Slovin SF, et al. Among authors: larson sm. Clin Cancer Res. 1998 Mar;4(3):643-51. Clin Cancer Res. 1998. PMID: 9533532

10

A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI. Imbriaco M, et al. Among authors: larson sm. Clin Cancer Res. 1998 Jul;4(7):1765-72. Clin Cancer Res. 1998. PMID: 9676853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

684 results

Search Page

Filters